位置:首页 > 蛋白库 > YTHD1_MOUSE
YTHD1_MOUSE
ID   YTHD1_MOUSE             Reviewed;         559 AA.
AC   P59326; Q3T9E2;
DT   12-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   12-FEB-2003, sequence version 1.
DT   03-AUG-2022, entry version 121.
DE   RecName: Full=YTH domain-containing family protein 1 {ECO:0000305};
DE   AltName: Full=Dermatomyositis associated with cancer putative autoantigen 1 homolog {ECO:0000250|UniProtKB:Q9BYJ9};
DE            Short=DACA-1 homolog {ECO:0000250|UniProtKB:Q9BYJ9};
GN   Name=Ythdf1 {ECO:0000303|PubMed:30401835, ECO:0000312|MGI:MGI:1917431};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Medulla oblongata, and Spleen;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Embryo;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [4]
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=30401835; DOI=10.1038/s41586-018-0666-1;
RA   Shi H., Zhang X., Weng Y.L., Lu Z., Liu Y., Lu Z., Li J., Hao P., Zhang Y.,
RA   Zhang F., Wu Y., Delgado J.Y., Su Y., Patel M.J., Cao X., Shen B.,
RA   Huang X., Ming G.L., Zhuang X., Song H., He C., Zhou T.;
RT   "m6A facilitates hippocampus-dependent learning and memory through
RT   YTHDF1.";
RL   Nature 563:249-253(2018).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=30728504; DOI=10.1038/s41586-019-0916-x;
RA   Han D., Liu J., Chen C., Dong L., Liu Y., Chang R., Huang X., Liu Y.,
RA   Wang J., Dougherty U., Bissonnette M.B., Shen B., Weichselbaum R.R.,
RA   Xu M.M., He C.;
RT   "Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in
RT   dendritic cells.";
RL   Nature 566:270-274(2019).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=30843071; DOI=10.1093/nar/gkz157;
RA   Zhuang M., Li X., Zhu J., Zhang J., Niu F., Liang F., Chen M., Li D.,
RA   Han P., Ji S.J.;
RT   "The m6A reader YTHDF1 regulates axon guidance through translational
RT   control of Robo3.1 expression.";
RL   Nucleic Acids Res. 47:4765-4777(2019).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=32943573; DOI=10.1101/gad.340695.120;
RA   Lasman L., Krupalnik V., Viukov S., Mor N., Aguilera-Castrejon A.,
RA   Schneir D., Bayerl J., Mizrahi O., Peles S., Tawil S., Sathe S.,
RA   Nachshon A., Shani T., Zerbib M., Kilimnik I., Aigner S., Shankar A.,
RA   Mueller J.R., Schwartz S., Stern-Ginossar N., Yeo G.W., Geula S.,
RA   Novershtern N., Hanna J.H.;
RT   "Context-dependent functional compensation between Ythdf m6A reader
RT   proteins.";
RL   Genes Dev. 34:1373-1391(2020).
CC   -!- FUNCTION: Specifically recognizes and binds N6-methyladenosine (m6A)-
CC       containing mRNAs, and regulates their stability (PubMed:30401835,
CC       PubMed:32943573). M6A is a modification present at internal sites of
CC       mRNAs and some non-coding RNAs and plays a role in mRNA stability and
CC       processing (PubMed:30401835, PubMed:32943573). Acts as a regulator of
CC       mRNA stability by promoting degradation of m6A-containing mRNAs via
CC       interaction with the CCR4-NOT complex (By similarity). The YTHDF
CC       paralogs (YTHDF1, YTHDF2 and YTHDF3) share m6A-containing mRNAs targets
CC       and act redundantly to mediate mRNA degradation and cellular
CC       differentiation (PubMed:32943573). Required to facilitate learning and
CC       memory formation in the hippocampus by binding to m6A-containing
CC       neuronal mRNAs (PubMed:30401835). Acts as a regulator of axon guidance
CC       by binding to m6A-containing ROBO3 transcripts (PubMed:30843071). Acts
CC       as a negative regulator of antigen cross-presentation in myeloid
CC       dendritic cells (PubMed:30728504). In the context of tumorigenesis,
CC       negative regulation of antigen cross-presentation limits the anti-tumor
CC       response by reducing efficiency of tumor-antigen cross-presentation
CC       (PubMed:30728504). Promotes formation of phase-separated membraneless
CC       compartments, such as P-bodies or stress granules, by undergoing
CC       liquid-liquid phase separation upon binding to mRNAs containing
CC       multiple m6A-modified residues: polymethylated mRNAs act as a
CC       multivalent scaffold for the binding of YTHDF proteins, juxtaposing
CC       their disordered regions and thereby leading to phase separation (By
CC       similarity). The resulting mRNA-YTHDF complexes then partition into
CC       different endogenous phase-separated membraneless compartments, such as
CC       P-bodies, stress granules or neuronal RNA granules (By similarity).
CC       {ECO:0000250|UniProtKB:Q9BYJ9, ECO:0000269|PubMed:30401835,
CC       ECO:0000269|PubMed:30728504, ECO:0000269|PubMed:30843071,
CC       ECO:0000269|PubMed:32943573}.
CC   -!- SUBUNIT: Interacts with CNOT1; promoting recruitment of the CCR4-NOT
CC       complex (By similarity). Interacts with ribosomes (By similarity).
CC       Interacts with eIF3 (EIF3A or EIF3B). Interacts with YTHDF3 (By
CC       similarity). {ECO:0000250|UniProtKB:Q9BYJ9}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:32943573}.
CC       Cytoplasm, P-body {ECO:0000250|UniProtKB:Q9BYJ9}. Cytoplasm, Stress
CC       granule {ECO:0000250|UniProtKB:Q9BYJ9}.
CC   -!- TISSUE SPECIFICITY: In brain, preferentially expressed in the
CC       hippocampus. {ECO:0000269|PubMed:30401835}.
CC   -!- DOMAIN: The disordered regions have the ability to interact with each
CC       other and to 'phase separate' into liquid droplets within the cytosol
CC       following binding to mRNAs containing multiple m6A-modified residues.
CC       This leads to the partition of m6A-containing mRNAs into membraneless
CC       compartments, where mRNAs may be stored, degraded or used to transport
CC       mRNAs to dendritic arbors in neurons. {ECO:0000250|UniProtKB:Q9BYJ9}.
CC   -!- DISRUPTION PHENOTYPE: Mice are viable and were born at the expected
CC       Mendelian ratio (PubMed:32943573). They however display learning and
CC       memory defects (PubMed:30401835). Mice develop normally up to four
CC       months of age and have normal gross hippocampal histology
CC       (PubMed:30401835). They however show learning and memory defects as
CC       well as impaired hippocampal synaptic transmission and long-term
CC       potentiation (PubMed:30401835). Hippocampal CA1 neurons show reduced
CC       dendritic spine density but unaltered spine size (PubMed:30401835).
CC       Conditional deletion in spinal commissural neurons results in pre-
CC       crossing axon guidance defects (PubMed:30843071). Knockout mice show an
CC       improved tumor control associated with increased infiltration of the
CC       tumor by T-cells, due to elevated antigen-specific CD8(+) T-cell anti-
CC       tumor response (PubMed:30728504). Conditional deletion in myeloid
CC       dendritic cells causes increased cross-presentation of tumor antigens
CC       and the cross-priming of CD8(+) T-cells (PubMed:30728504). Mice lacking
CC       Ythdf1, Ythdf2 and Ythdf3 display early embryonic lethality and show
CC       defects in embryonic stem cell differentiation (PubMed:32943573).
CC       {ECO:0000269|PubMed:30401835, ECO:0000269|PubMed:30728504,
CC       ECO:0000269|PubMed:30843071, ECO:0000269|PubMed:32943573}.
CC   -!- SIMILARITY: Belongs to the YTHDF family. YTHDF1 subfamily.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was initially reported to act as a regulator of mRNA
CC       translation efficiency by promoting ribosome loading to m6A-containing
CC       mRNAs and by interacting with translation initiation factors eIF3
CC       (EIF3A or EIF3B), thereby facilitating translation initiation
CC       (PubMed:30401835, PubMed:30728504, PubMed:30843071). These studies
CC       suggested that the 3 different paralogs (YTHDF1, YTHDF2 and YTHDF3)
CC       have unique functions with limited redundancy (PubMed:30401835,
CC       PubMed:30728504, PubMed:30843071). However, later studies showed that
CC       YTHDF1, YTHDF2 and YTHDF3 paralogs have redundant functions to a
CC       profound extent and directly promote degradation of m6A-containing
CC       mRNAs (PubMed:32943573). The effect on translation efficiency observed
CC       earlier is probably indirect (PubMed:32943573).
CC       {ECO:0000269|PubMed:30401835, ECO:0000269|PubMed:30728504,
CC       ECO:0000269|PubMed:30843071, ECO:0000269|PubMed:32943573}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK046768; BAC32861.1; -; mRNA.
DR   EMBL; AK172582; BAE43080.1; -; mRNA.
DR   EMBL; BC061479; AAH61479.1; -; mRNA.
DR   EMBL; BC065050; AAH65050.1; -; mRNA.
DR   CCDS; CCDS17188.1; -.
DR   RefSeq; NP_776122.1; NM_173761.3.
DR   AlphaFoldDB; P59326; -.
DR   SMR; P59326; -.
DR   BioGRID; 230804; 8.
DR   STRING; 10090.ENSMUSP00000037808; -.
DR   iPTMnet; P59326; -.
DR   PhosphoSitePlus; P59326; -.
DR   EPD; P59326; -.
DR   MaxQB; P59326; -.
DR   PaxDb; P59326; -.
DR   PRIDE; P59326; -.
DR   ProteomicsDB; 275120; -.
DR   Antibodypedia; 44459; 149 antibodies from 26 providers.
DR   DNASU; 228994; -.
DR   Ensembl; ENSMUST00000037299; ENSMUSP00000037808; ENSMUSG00000038848.
DR   GeneID; 228994; -.
DR   KEGG; mmu:228994; -.
DR   UCSC; uc008okd.1; mouse.
DR   CTD; 54915; -.
DR   MGI; MGI:1917431; Ythdf1.
DR   VEuPathDB; HostDB:ENSMUSG00000038848; -.
DR   eggNOG; KOG1901; Eukaryota.
DR   GeneTree; ENSGT00940000156911; -.
DR   HOGENOM; CLU_022715_0_0_1; -.
DR   InParanoid; P59326; -.
DR   OMA; DIGTWDH; -.
DR   OrthoDB; 1523251at2759; -.
DR   PhylomeDB; P59326; -.
DR   TreeFam; TF323736; -.
DR   BioGRID-ORCS; 228994; 6 hits in 74 CRISPR screens.
DR   PRO; PR:P59326; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; P59326; protein.
DR   Bgee; ENSMUSG00000038848; Expressed in paneth cell and 264 other tissues.
DR   ExpressionAtlas; P59326; baseline and differential.
DR   Genevisible; P59326; MM.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0010494; C:cytoplasmic stress granule; ISS:UniProtKB.
DR   GO; GO:0000932; C:P-body; ISS:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:1990247; F:N6-methyladenosine-containing RNA binding; IDA:UniProtKB.
DR   GO; GO:0043022; F:ribosome binding; ISS:UniProtKB.
DR   GO; GO:0002376; P:immune system process; IEA:UniProtKB-KW.
DR   GO; GO:0007612; P:learning; IMP:UniProtKB.
DR   GO; GO:0007613; P:memory; IMP:UniProtKB.
DR   GO; GO:0061157; P:mRNA destabilization; IMP:UniProtKB.
DR   GO; GO:0070925; P:organelle assembly; ISS:UniProtKB.
DR   GO; GO:0045727; P:positive regulation of translation; IDA:UniProtKB.
DR   GO; GO:0045948; P:positive regulation of translational initiation; ISS:UniProtKB.
DR   GO; GO:0002577; P:regulation of antigen processing and presentation; IMP:UniProtKB.
DR   GO; GO:1902667; P:regulation of axon guidance; IMP:UniProtKB.
DR   GO; GO:1900271; P:regulation of long-term synaptic potentiation; IMP:UniProtKB.
DR   GO; GO:0043488; P:regulation of mRNA stability; IMP:UniProtKB.
DR   GO; GO:0034063; P:stress granule assembly; ISS:UniProtKB.
DR   InterPro; IPR007275; YTH_domain.
DR   InterPro; IPR045168; YTH_prot.
DR   PANTHER; PTHR12357; PTHR12357; 1.
DR   Pfam; PF04146; YTH; 1.
DR   PROSITE; PS50882; YTH; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; Immunity; Phosphoprotein; Reference proteome;
KW   RNA-binding.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BYJ9"
FT   CHAIN           2..559
FT                   /note="YTH domain-containing family protein 1"
FT                   /id="PRO_0000223074"
FT   DOMAIN          389..523
FT                   /note="YTH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00225"
FT   REGION          1..49
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          239..365
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..23
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        291..317
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        338..362
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         395..397
FT                   /ligand="RNA"
FT                   /ligand_id="ChEBI:CHEBI:33697"
FT                   /ligand_part="N(6)-methyladenosine 5'-phosphate residue"
FT                   /ligand_part_id="ChEBI:CHEBI:74449"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BYJ9"
FT   BINDING         401
FT                   /ligand="RNA"
FT                   /ligand_id="ChEBI:CHEBI:33697"
FT                   /ligand_part="N(6)-methyladenosine 5'-phosphate residue"
FT                   /ligand_part_id="ChEBI:CHEBI:74449"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BYJ9"
FT   BINDING         411..412
FT                   /ligand="RNA"
FT                   /ligand_id="ChEBI:CHEBI:33697"
FT                   /ligand_part="N(6)-methyladenosine 5'-phosphate residue"
FT                   /ligand_part_id="ChEBI:CHEBI:74449"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BYJ9"
FT   BINDING         441
FT                   /ligand="RNA"
FT                   /ligand_id="ChEBI:CHEBI:33697"
FT                   /ligand_part="N(6)-methyladenosine 5'-phosphate residue"
FT                   /ligand_part_id="ChEBI:CHEBI:74449"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y5A9"
FT   BINDING         465
FT                   /ligand="RNA"
FT                   /ligand_id="ChEBI:CHEBI:33697"
FT                   /ligand_part="N(6)-methyladenosine 5'-phosphate residue"
FT                   /ligand_part_id="ChEBI:CHEBI:74449"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BYJ9"
FT   BINDING         470
FT                   /ligand="RNA"
FT                   /ligand_id="ChEBI:CHEBI:33697"
FT                   /ligand_part="N(6)-methyladenosine 5'-phosphate residue"
FT                   /ligand_part_id="ChEBI:CHEBI:74449"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BYJ9"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BYJ9"
FT   MOD_RES         182
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BYJ9"
SQ   SEQUENCE   559 AA;  60879 MW;  2DFA0E2D8751FA24 CRC64;
     MSATSVDPQR TKGQDNKVQN GSLHQKDAVH DNDFEPYLSG QSNPSNSYPS MSDPYLSSYY
     PPSIGFPYSL SEAPWSTAGD PPIPYLTTYG QLSNGDHHFM HDAVFGQPGG LGNNIYQHRF
     NFFPENPAFS AWGTSGSQGQ QTQSSAYGSS YTYPPSSLGG TVVDGQTGFH SDSLNKAPGM
     NSLEQGMVGL KIGDVTTSAV KTVGSVVNSV ALTGVLSGNG GTNVNMPVSK PTSWAAIASK
     PAKPQPKMKT KSGPIVGGAL PPPPIKHNMD IGTWDNKGPA PKASAPQQTP SPQAAPQPQQ
     VAQPLPVQPP PLVQPQYQSP QQPLQPRWVA PRNRNAAFGQ SGGANSDSNS VGNAQPTSAP
     SVESHPVLEK LKAAHSYNPK EFDWNLKSGR VFIIKSYSED DIHRSIKYSI WCSTEHGNKR
     LDGAFRSMSS KGPVYLLFSV NGSGHFCGVA EMKSPVDYGT SAGVWSQDKW KGKFDVKWIF
     VKDVPNNQLR HIRLENNDNK PVTNSRDTQE VPLEKAKQVL KIIASYKHTT SIFDDFSHYE
     KRQEEEEVVR KERQNRNKQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024